Retroperitoneal fibrosis and β-blocking agents: Is there an association?
Hardjit KharagjitsingRike van EekerenEugène P van PuijenbroekTeun van GelderEric F H van BommelPublished in: British journal of clinical pharmacology (2021)
Although disproportionality analysis indicated a potential safety signal for RPF associated with BBAs, clinical evidence did not support a cause-and-effect relationship.
Keyphrases